Author Taylor, Peggy

• 2013 | Journal Article
  ​ ​Total CSF alpha-synuclein is lower in de novo Parkinson patients than in healthy subjects​
  Mollenhauer, B.; Trautmann, E.; Taylor, P.; Manninger, P.; Sixel-Doering, F.; Ebentheuer, J. & Trenkwalder, C. et al.​ (2013) 
  Neuroscience Letters, 532 pp. 44​-48​.​ DOI: https://doi.org/10.1016/j.neulet.2012.11.004 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article
  ​ ​Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study​
  Kruse, N.; Persson, S.; Alcolea, D.; Bahl, J. M. C.; Baldeiras, I.; Capello, E. & Chiasserini, D. et al.​ (2015) 
  Neurobiology of Aging, 36(9) pp. 2587​-2596​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2015.05.003 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​Monitoring of 30 marker candidates in early Parkinson disease as progression markers​
  Mollenhauer, B. ; Zimmermann, J.; Sixel-Döring, F.; Focke, N. K. ; Wicke, T.; Ebentheuer, J. & Schaumburg, M. et al.​ (2016) 
  Neurology, 87(2) pp. 168​-177​.​ DOI: https://doi.org/10.1212/WNL.0000000000002651 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Journal Article
  ​ ​CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study​
  Kang, J.-H.; Mollenhauer, B.; Coffey, C. S.; Toledo, J. B.; Weintraub, D.; Galasko, D. R. & Irwin, D. J. et al.​ (2016) 
  Acta Neuropathologica, 131(6) pp. 935​-949​.​ DOI: https://doi.org/10.1007/s00401-016-1552-2 
  ​Details  DOI  PMID  PMC  WoS 

• 2017 | Journal Article | 
  ​ ​Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease​
  Eidson, L. N.; Kannarkat, G. T.; Barnum, C. J.; Chang, J.; Chung, J.; Caspell-Garcia, C. & Taylor, P. et al.​ (2017) 
  Journal of Neuroinflammation, 14(1).​ DOI: https://doi.org/10.1186/s12974-017-0935-1 
  ​Details  DOI 

• 2017 | Journal Article
  ​ ​A user's guide for α-synuclein biomarker studies in biological fluids: ​Perianalytical considerations​
  Mollenhauer, B. ; Batrla, R.; El-Agnaf, O.; Galasko, D. R; Lashuel, H.; Merchant, K. & Shaw, L. M et al.​ (2017) 
  Movement Disorders, 32(8) pp. 1117​-1130​.​ DOI: https://doi.org/10.1002/mds.27090 
  ​Details  DOI  PMID  PMC 

• 2017 | Journal Article | 
  ​ ​Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls​
  Mollenhauer, B. ; Caspell-Garcia, C. J; Coffey, C.; Taylor, P.; Shaw, L. M.; Trojanowski, J. Q. & Singleton, A. et al.​ (2017) 
  Neurology, 89(19) pp. 1959​-1969​.​ DOI: https://doi.org/10.1212/WNL.0000000000004609 
  ​Details  DOI  PMID  PMC 

• 2019 | Journal Article | 
  ​ ​Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease​
  Mollenhauer, B.; Caspell‐Garcia, C. J.; Coffey, C. S.; Taylor, P.; Singleton, A.; Shaw, L. M. & Trojanowski, J. Q. et al.​ (2019) 
  Movement Disorders, 34(9) pp. 1354​-1364​.​ DOI: https://doi.org/10.1002/mds.27806 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study​
  Mollenhauer, B.; Bowman, F. D.; Drake, D.; Duong, J.; Blennow, K.; El‐Agnaf, O. & Shaw, L. M. et al.​ (2019) 
  Journal of Neurochemistry, 149(1) pp. 126​-138​.​ DOI: https://doi.org/10.1111/jnc.14569 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article
  ​ ​In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease​
  Chahine, L. M.; Beach, T. G.; Brumm, M. C.; Adler, C. H.; Coffey, C. S.; Mosovsky, S. & Caspell-Garcia, C. et al.​ (2020) 
  Neurology, 95(9) pp. e1267​-e1284​.​ DOI: https://doi.org/10.1212/WNL.0000000000010404 
  ​Details  DOI 

Researcher

Sort

Items per Page